Product Overview

AOP Orphan's focus is on rare and special diseases. The portfolio comprises products in the following therapeutic areas: HematoOncology, Cardiology & Pulmonology, Neurology and Metabolic Disorders and Intensive Care. AOP Orphan’s strategic goal is to constantly deliver new treatment options with respect to rare and special diseases. 

Cardiology & Pulmonology

Ambrisentan AOP

is used to treat pulmonary arterial hypertension in adults.

Drug Facts
Active Ingredient
Ambrisentant
Cardiology & Pulmonology

TRESUVI®

Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) for improving exercise capacity and alleviate disease symptoms in patients with New York Heart Association (NYHA) Functional Class III.

Drug Facts
Active Ingredient
Treprostinil
Cardiology & Pulmonology

TRISUVA®

Treatment of idiopathic or hereditary pulmonary arterial hypertension (PAH) for improving exercise capacity and alleviate disease symptoms in patients with New York Heart Association (NYHA) Functional Class III.

Drug Facts
Active Ingredient
Treprostinil-Natrium
Cardiology & Pulmonology

Tadalalfil AOP

Tadalafil AOP is used to treat adults with pulmonary arterial hypertension (PAH) to improve exercise capacity (the ability to carry out physical activity).

Drug Facts
Active Ingredient
Cardiology & Pulmonology

Treprostinil Amomed®

Treprostinil Amomed® is used to treat pulmonary arterial hypertension.

Drug Facts
Active Ingredient
Treprostinil
Cardiology & Pulmonology

Trepulmix®

Trepulmix is indicated for the treatment of adult patients with WHO Functional Class (FC) III or IV and - inoperable chronic thromboembolic pulmonary hypertension (CTEPH), or - persistent or recurrent CTEPH after surgical treatment to improve exercise capacity.

Drug Facts
Active Ingredient
Trepulmix